GENE ONLINE|News &
Opinion
Blog

Ono Pharmaceutical
R&D Opdivo
Taiwan Greenlights BMS, Ono’s Opdivo For Frontline Esophageal Cancer
2022-07-20
Asia-Pacific Neurodegenerative Disease
Japan’s Ono Pharmaceutical Expands Collab with Neurimmune to Discover Antibodies for Neurodegenerative Disorders
2022-01-18
Anti-epileptic Drug
South Korean Biotech Finds Strategic Partner to Advance Epileptic Treatment Options
2020-10-15
Trials & Approvals PD-L1
BMS Enters Esophageal Cancer Therapy Area Amidst High Competition
2020-09-27
LATEST
The Impact of “Inner Excellence” on A.J. Brown’s Performance and Mindset
2025-01-14
Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in Oncology
2025-01-10
United Imaging Announces Major Expansion of U.S. Manufacturing Space
2025-01-09
Posdinemab Becomes J&J’s Second FDA Fast Track Designation Targeting Phosphorylated Tau in Alzheimer’s Disease
2025-01-09
Key Market Trends Shaping Health Systems and Specialty Pharmacies
2025-01-08
COVID Caused Cancer Tumors to Shrink in Mice and We Want to Know How
2025-01-08
Catapulting Stem Cell Research into the Future: Innovation and Global Impact at ISSCR 2025 in Hong Kong
2025-01-08
READ MORE
EVENT
2025-01-13
Biotech Showcase 2025
San Francisco, California
2025-01-13
JP Morgan Healthcare Conference
San Francisco, California
2025-02-05
Precision Medicine World Conference 2025
Santa Clara, California
2025-02-19
Healthcare Conference Taipei 2025
Taipei, Taiwan
2025-03-17
BIO-Europe Spring 2025
Milan, Italy
2025-04-02
Asia Cell and Gene Therapy Innovation Summit 2025
Shanghai, China
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2025 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top